Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001411690-22-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-17 | 2022-08-15 | BNGO | Linney Yvonne | Dir | M - OptEx | $0.38 | +20.0K | 20.0K | New | +$7,600 |
| D | 2022-08-17 | 2022-08-15 | BNGO | Linney Yvonne | Dir | S - Sale+OE | $3.62 | -20.0K | 0 | -100% | -$72.4K |
| D | 2022-08-17 | 2022-08-15 | BNGO | Linney Yvonne | Dir | M - OptEx | $0.00 | -20.0K | 60.9K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-15 | M | A | 20,000 | $0.38 | 20,000 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-15 | S | D | 20,000 | $3.62 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-08-15 | M | D | 20,000 | $0.00 | 60,923 | D | $0.38 · — to 2030-05-04 | 20,000 Common Stock | (F1) The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan). |